ArticleOncogene2022

HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.

Elyse C Page et al.PubMed ↗Publisher ↗

No numbers read from the abstract.